Tango Therapeutics, Inc. current ratio

The Current Ratio as of November 2026 (TTM) for Tango Therapeutics, Inc. (TNGX) is 50.82

According to Tango Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 50.82. This represents a change of 96.61% compared to the average of 25.85 of the last 4 quarters.

Tango Therapeutics, Inc. (TNGX) Historical Current Ratio (quarterly & annually)

How has TNGX Current Ratio performed in the past?

The mean historical Current Ratio of Tango Therapeutics, Inc. over the last ten years is 8.01. The current 50.82 Current Ratio has changed 534.86% with respect to the historical average. Over the past ten years (40 quarters), TNGX's Current Ratio was at its highest in in the June 2026 quarter at 50.82. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Tango Therapeutics, Inc. (TNGX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Tango Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tango Therapeutics, Inc. (TNGX) Average Current Ratio

How has TNGX Current Ratio performed in the past?

The current Current Ratio of Tango Therapeutics, Inc. (TNGX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tango Therapeutics, Inc. (TNGX) Current Ratio vs. Peers

How is TNGX’s Current Ratio compared to its peers?

Tango Therapeutics, Inc.’s Current Ratio is greater than IDEAYA Biosciences, Inc. (9.04), greater than Revolution Medicines, Inc. (8.36), greater than Prelude Therapeutics Incorporated (4.07), greater than Foghorn Therapeutics Inc. (3.36), greater than Erasca, Inc. (8.29), greater than Nurix Therapeutics, Inc. (8.44), greater than Acrivon Therapeutics, Inc. Common Stock (7.99), greater than Relay Therapeutics, Inc. (14.62), greater than Nuvation Bio Inc. (8.37), greater than C4 Therapeutics, Inc. (5.45),

Build a custom stock screener for Tango Therapeutics, Inc. (TNGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tango Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tango Therapeutics, Inc. (TNGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tango Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.